NMPA Approval

Clindamycin Palmitate Hydrochloride Dispersible Tablets

Approval Number

国药准字H20173106

Company广州市联瑞制药有限公司

Registration Date

September 26, 2019

Drug Information

Generic Name

盐酸克林霉素棕榈酸酯分散片

Dosage Form

片剂

Strength

37.5mg（以C₁₈H₃₃ClN₂0₅S计）

Drug Type

化学药品

Registration Date

September 26, 2019

Company Information

Applicant Company

Company Name广州市联瑞制药有限公司

Company Address

广州市南沙区万顷沙镇同发路2号自编101栋5层

Manufacturing Company

Company Name广州一品红制药有限公司

Company Address

广州市经济技术开发区东区东博路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸克林霉素棕榈酸酯分散片 - NMPA 批准文号 | MedPath